Epstein Secrets

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

tdowns." Reuters <https://www.reuters.corrilarticle/us-usa-stocks/sp-dips-on-worries-about-eamings-data-stimulus-and-election- idUSKCN24V1Y7> (7/30, Carew) reports "the Dow Jones Industrial Average fell 225.92 points, or 0.85%, to 26,313.65, the S&P 500 lost 12.22 points, or 0.38%, to 3,246.22 and the

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

nomic contraction in the second quarter as the coronavirus pandemic battered the economy, leading to widespread business shutdowns." Reuters (7/30, Carew) reports "the Dow Jones Industrial Average fell EFTA00150196 225.92 points, or 0.85%, to 26,313.65, the S&P 500 lost 12.22 points, or 0.38%, to 3,

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

nomic contraction in the second quarter as the coronavirus pandemic battered the economy, leading to widespread business shutdowns." Reuters (7/30, Carew) reports "the Dow Jones Industrial Average fell 225.92 points, or 0.85%, to 26,313.65, the S&P 500 lost 12.22 points, or 0.38%, to 3,246.22 and the